|
1
|
A comprehensive classification system for lipids.
|
J Lipid Res
|
2005
|
6.52
|
|
2
|
Pneumococcal vaccination decreases atherosclerotic lesion formation: molecular mimicry between Streptococcus pneumoniae and oxidized LDL.
|
Nat Med
|
2003
|
4.47
|
|
3
|
Innate and acquired immunity in atherogenesis.
|
Nat Med
|
2002
|
4.22
|
|
4
|
Oxidized phospholipids, Lp(a) lipoprotein, and coronary artery disease.
|
N Engl J Med
|
2005
|
4.16
|
|
5
|
Lipoprotein management in patients with cardiometabolic risk: consensus statement from the American Diabetes Association and the American College of Cardiology Foundation.
|
Diabetes Care
|
2008
|
3.65
|
|
6
|
Atherogenic lipids and lipoproteins trigger CD36-TLR2-dependent apoptosis in macrophages undergoing endoplasmic reticulum stress.
|
Cell Metab
|
2010
|
3.29
|
|
7
|
Differential inhibition of macrophage foam-cell formation and atherosclerosis in mice by PPARalpha, beta/delta, and gamma.
|
J Clin Invest
|
2004
|
3.23
|
|
8
|
Lipoprotein management in patients with cardiometabolic risk: consensus conference report from the American Diabetes Association and the American College of Cardiology Foundation.
|
J Am Coll Cardiol
|
2008
|
3.15
|
|
9
|
Oxidation-specific epitopes are danger-associated molecular patterns recognized by pattern recognition receptors of innate immunity.
|
Circ Res
|
2011
|
2.89
|
|
10
|
Is the oxidative modification hypothesis relevant to human atherosclerosis? Do the antioxidant trials conducted to date refute the hypothesis?
|
Circulation
|
2002
|
2.80
|
|
11
|
Oxidation-specific epitopes are dominant targets of innate natural antibodies in mice and humans.
|
J Clin Invest
|
2009
|
2.75
|
|
12
|
Minimally modified LDL binds to CD14, induces macrophage spreading via TLR4/MD-2, and inhibits phagocytosis of apoptotic cells.
|
J Biol Chem
|
2002
|
2.66
|
|
13
|
Complement factor H binds malondialdehyde epitopes and protects from oxidative stress.
|
Nature
|
2011
|
2.64
|
|
14
|
IL-5 links adaptive and natural immunity specific for epitopes of oxidized LDL and protects from atherosclerosis.
|
J Clin Invest
|
2004
|
2.56
|
|
15
|
Liver heparan sulfate proteoglycans mediate clearance of triglyceride-rich lipoproteins independently of LDL receptor family members.
|
J Clin Invest
|
2007
|
2.53
|
|
16
|
Critical role of IL-17RA in immunopathology of influenza infection.
|
J Immunol
|
2009
|
2.51
|
|
17
|
Deficiency of cathepsin S reduces atherosclerosis in LDL receptor-deficient mice.
|
J Clin Invest
|
2003
|
2.48
|
|
18
|
Toll-like receptor 4-dependent and -independent cytokine secretion induced by minimally oxidized low-density lipoprotein in macrophages.
|
Arterioscler Thromb Vasc Biol
|
2005
|
2.41
|
|
19
|
C-reactive protein binds to both oxidized LDL and apoptotic cells through recognition of a common ligand: Phosphorylcholine of oxidized phospholipids.
|
Proc Natl Acad Sci U S A
|
2002
|
2.20
|
|
20
|
C-reactive protein, an 'intermediate phenotype' for inflammation: human twin studies reveal heritability, association with blood pressure and the metabolic syndrome, and the influence of common polymorphism at catecholaminergic/beta-adrenergic pathway loci.
|
J Hypertens
|
2007
|
2.19
|
|
21
|
Apoptotic cells with oxidation-specific epitopes are immunogenic and proinflammatory.
|
J Exp Med
|
2004
|
2.10
|
|
22
|
Targeting APOC3 in the familial chylomicronemia syndrome.
|
N Engl J Med
|
2014
|
2.06
|
|
23
|
Antisense Inhibition of Apolipoprotein C-III in Patients with Hypertriglyceridemia.
|
N Engl J Med
|
2015
|
2.03
|
|
24
|
Macrophages generate reactive oxygen species in response to minimally oxidized low-density lipoprotein: toll-like receptor 4- and spleen tyrosine kinase-dependent activation of NADPH oxidase 2.
|
Circ Res
|
2008
|
1.98
|
|
25
|
High-dose atorvastatin reduces total plasma levels of oxidized phospholipids and immune complexes present on apolipoprotein B-100 in patients with acute coronary syndromes in the MIRACL trial.
|
Circulation
|
2004
|
1.97
|
|
26
|
Oxidative damage in multiple sclerosis lesions.
|
Brain
|
2011
|
1.95
|
|
27
|
Evidence mandating earlier and more aggressive treatment of hypercholesterolemia.
|
Circulation
|
2008
|
1.91
|
|
28
|
Vascular lipid accumulation, lipoprotein oxidation, and macrophage lipid uptake in hypercholesterolemic zebrafish.
|
Circ Res
|
2009
|
1.89
|
|
29
|
Lipid peroxidation is enhanced in patients with systemic lupus erythematosus and is associated with arterial and renal disease manifestations.
|
Arthritis Rheum
|
2005
|
1.89
|
|
30
|
T-bet deficiency reduces atherosclerosis and alters plaque antigen-specific immune responses.
|
Proc Natl Acad Sci U S A
|
2005
|
1.82
|
|
31
|
Oxidized phospholipids, lipoprotein(a), lipoprotein-associated phospholipase A2 activity, and 10-year cardiovascular outcomes: prospective results from the Bruneck study.
|
Arterioscler Thromb Vasc Biol
|
2007
|
1.79
|
|
32
|
A novel function of lipoprotein [a] as a preferential carrier of oxidized phospholipids in human plasma.
|
J Lipid Res
|
2008
|
1.79
|
|
33
|
Impaired regulatory T-cell response and enhanced atherosclerosis in the absence of inducible costimulatory molecule.
|
Circulation
|
2006
|
1.77
|
|
34
|
Phosphoinositide 3-kinase p110 delta regulates natural antibody production, marginal zone and B-1 B cell function, and autoantibody responses.
|
J Immunol
|
2009
|
1.77
|
|
35
|
Antioxidant vitamin supplements and cardiovascular disease.
|
Circulation
|
2004
|
1.76
|
|
36
|
Critical role of macrophage 12/15-lipoxygenase for atherosclerosis in apolipoprotein E-deficient mice.
|
Circulation
|
2004
|
1.70
|
|
37
|
Reduced in vivo aortic uptake of radiolabeled oxidation-specific antibodies reflects changes in plaque composition consistent with plaque stabilization.
|
Arterioscler Thromb Vasc Biol
|
2004
|
1.68
|
|
38
|
Targeted molecular probes for imaging atherosclerotic lesions with magnetic resonance using antibodies that recognize oxidation-specific epitopes.
|
Circulation
|
2008
|
1.68
|
|
39
|
Correlation of antiphospholipid antibody recognition with the structure of synthetic oxidized phospholipids. Importance of Schiff base formation and aldol condensation.
|
J Biol Chem
|
2001
|
1.67
|
|
40
|
Temporal increases in plasma markers of oxidized low-density lipoprotein strongly reflect the presence of acute coronary syndromes.
|
J Am Coll Cardiol
|
2003
|
1.66
|
|
41
|
The role of natural antibodies in atherogenesis.
|
J Lipid Res
|
2005
|
1.65
|
|
42
|
Macrophage apoptosis exerts divergent effects on atherogenesis as a function of lesion stage.
|
Circulation
|
2009
|
1.65
|
|
43
|
Lipoprotein accumulation in macrophages via toll-like receptor-4-dependent fluid phase uptake.
|
Circ Res
|
2009
|
1.63
|
|
44
|
Oxidized membrane vesicles and blebs from apoptotic cells contain biologically active oxidized phospholipids that induce monocyte-endothelial interactions.
|
Arterioscler Thromb Vasc Biol
|
2002
|
1.62
|
|
45
|
Helix-loop-helix factor inhibitor of differentiation 3 regulates interleukin-5 expression and B-1a B cell proliferation.
|
Arterioscler Thromb Vasc Biol
|
2013
|
1.61
|
|
46
|
Relationship of IgG and IgM autoantibodies to oxidized low density lipoprotein with coronary artery disease and cardiovascular events.
|
J Lipid Res
|
2006
|
1.61
|
|
47
|
Phosphocholine as a pattern recognition ligand for CD36.
|
J Lipid Res
|
2005
|
1.59
|
|
48
|
Changes in dietary fat intake alter plasma levels of oxidized low-density lipoprotein and lipoprotein(a).
|
Arterioscler Thromb Vasc Biol
|
2004
|
1.58
|
|
49
|
Oxidized low-density lipoprotein and atherosclerosis.
|
Arterioscler Thromb Vasc Biol
|
2010
|
1.56
|
|
50
|
Syndecan-1 is the primary heparan sulfate proteoglycan mediating hepatic clearance of triglyceride-rich lipoproteins in mice.
|
J Clin Invest
|
2009
|
1.56
|
|
51
|
Oxidized phospholipids are present on plasminogen, affect fibrinolysis, and increase following acute myocardial infarction.
|
J Am Coll Cardiol
|
2012
|
1.55
|
|
52
|
Antisense oligonucleotide directed to human apolipoprotein B-100 reduces lipoprotein(a) levels and oxidized phospholipids on human apolipoprotein B-100 particles in lipoprotein(a) transgenic mice.
|
Circulation
|
2008
|
1.55
|
|
53
|
Host-derived oxidized phospholipids and HDL regulate innate immunity in human leprosy.
|
J Clin Invest
|
2008
|
1.54
|
|
54
|
Low doses of lipopolysaccharide and minimally oxidized low-density lipoprotein cooperatively activate macrophages via nuclear factor kappa B and activator protein-1: possible mechanism for acceleration of atherosclerosis by subclinical endotoxemia.
|
Circ Res
|
2010
|
1.51
|
|
55
|
Circulating autoantibodies to oxidized LDL correlate with impaired coronary endothelial function after cardiac transplantation.
|
Arterioscler Thromb Vasc Biol
|
2002
|
1.51
|
|
56
|
The role of innate immunity in atherogenesis.
|
J Lipid Res
|
2008
|
1.50
|
|
57
|
Antioxidant vitamins C and E improve endothelial function in children with hyperlipidemia: Endothelial Assessment of Risk from Lipids in Youth (EARLY) Trial.
|
Circulation
|
2003
|
1.49
|
|
58
|
Epoxyisoprostane and epoxycyclopentenone phospholipids regulate monocyte chemotactic protein-1 and interleukin-8 synthesis. Formation of these oxidized phospholipids in response to interleukin-1beta.
|
J Biol Chem
|
2001
|
1.44
|
|
59
|
Lipid lowering reduces oxidative stress and endothelial cell activation in rabbit atheroma.
|
Circulation
|
2002
|
1.43
|
|
60
|
Adaptive immunity in atherogenesis: new insights and therapeutic approaches.
|
J Clin Invest
|
2013
|
1.43
|
|
61
|
Percutaneous coronary intervention results in acute increases in oxidized phospholipids and lipoprotein(a): short-term and long-term immunologic responses to oxidized low-density lipoprotein.
|
Circulation
|
2004
|
1.43
|
|
62
|
Cholesteryl ester hydroperoxides are biologically active components of minimally oxidized low density lipoprotein.
|
J Biol Chem
|
2008
|
1.40
|
|
63
|
ABCA1 and ABCG1 protect against oxidative stress-induced macrophage apoptosis during efferocytosis.
|
Circ Res
|
2010
|
1.37
|
|
64
|
Influence of C3 deficiency on atherosclerosis.
|
Circulation
|
2002
|
1.37
|
|
65
|
The influence of pravastatin and atorvastatin on markers of oxidative stress in hypercholesterolemic humans.
|
J Am Coll Cardiol
|
2008
|
1.36
|
|
66
|
The autoreactivity of anti-phosphorylcholine antibodies for atherosclerosis-associated neo-antigens and apoptotic cells.
|
J Immunol
|
2003
|
1.36
|
|
67
|
Oxidized cholesteryl esters and phospholipids in zebrafish larvae fed a high cholesterol diet: macrophage binding and activation.
|
J Biol Chem
|
2010
|
1.35
|
|
68
|
Oxidation-specific biomarkers, lipoprotein(a), and risk of fatal and nonfatal coronary events.
|
J Am Coll Cardiol
|
2010
|
1.34
|
|
69
|
A diet-induced hypercholesterolemic murine model to study atherogenesis without obesity and metabolic syndrome.
|
Arterioscler Thromb Vasc Biol
|
2007
|
1.31
|
|
70
|
High-density lipoproteins retard the progression of atherosclerosis and favorably remodel lesions without suppressing indices of inflammation or oxidation.
|
Arterioscler Thromb Vasc Biol
|
2004
|
1.30
|
|
71
|
Oxidation-specific biomarkers, prospective 15-year cardiovascular and stroke outcomes, and net reclassification of cardiovascular events.
|
J Am Coll Cardiol
|
2012
|
1.30
|
|
72
|
In vivo visualization and attenuation of oxidized lipid accumulation in hypercholesterolemic zebrafish.
|
J Clin Invest
|
2011
|
1.27
|
|
73
|
The role of oxidized phospholipids in mediating lipoprotein(a) atherogenicity.
|
Curr Opin Lipidol
|
2008
|
1.27
|
|
74
|
Oxidized low density lipoprotein and innate immune receptors.
|
Curr Opin Lipidol
|
2003
|
1.26
|
|
75
|
The Bcl6-SMRT/NCoR cistrome represses inflammation to attenuate atherosclerosis.
|
Cell Metab
|
2012
|
1.24
|
|
76
|
Actin polymerization in macrophages in response to oxidized LDL and apoptotic cells: role of 12/15-lipoxygenase and phosphoinositide 3-kinase.
|
Mol Biol Cell
|
2003
|
1.23
|
|
77
|
Conventional dendritic cells at the crossroads between immunity and cholesterol homeostasis in atherosclerosis.
|
Circulation
|
2009
|
1.23
|
|
78
|
Oxidized phospholipids on apoB-100-containing lipoproteins: a biomarker predicting cardiovascular disease and cardiovascular events.
|
Biomark Med
|
2011
|
1.23
|
|
79
|
Antisense oligonucleotide lowers plasma levels of apolipoprotein (a) and lipoprotein (a) in transgenic mice.
|
J Am Coll Cardiol
|
2011
|
1.23
|
|
80
|
Lipid peroxidation in skeletal muscle of obese as compared to endurance-trained humans: a case of good vs. bad lipids?
|
FEBS Lett
|
2003
|
1.22
|
|
81
|
Oxidized phospholipids predict the presence and progression of carotid and femoral atherosclerosis and symptomatic cardiovascular disease: five-year prospective results from the Bruneck study.
|
J Am Coll Cardiol
|
2006
|
1.21
|
|
82
|
ApoE-/-Fas-/- C57BL/6 mice: a novel murine model simultaneously exhibits lupus nephritis, atherosclerosis, and osteopenia.
|
J Lipid Res
|
2007
|
1.21
|
|
83
|
Modifying apolipoprotein A-I by malondialdehyde, but not by an array of other reactive carbonyls, blocks cholesterol efflux by the ABCA1 pathway.
|
J Biol Chem
|
2010
|
1.19
|
|
84
|
High plasma leptin levels confer increased risk of atherosclerosis in women with systemic lupus erythematosus, and are associated with inflammatory oxidised lipids.
|
Ann Rheum Dis
|
2011
|
1.18
|
|
85
|
Differential expression of oxidation-specific epitopes and apolipoprotein(a) in progressing and ruptured human coronary and carotid atherosclerotic lesions.
|
J Lipid Res
|
2012
|
1.18
|
|
86
|
Human oxidation-specific antibodies reduce foam cell formation and atherosclerosis progression.
|
J Am Coll Cardiol
|
2011
|
1.16
|
|
87
|
Relationship of oxidized phospholipids on apolipoprotein B-100 particles to race/ethnicity, apolipoprotein(a) isoform size, and cardiovascular risk factors: results from the Dallas Heart Study.
|
Circulation
|
2009
|
1.16
|
|
88
|
Evidence for a novel human-specific xeno-auto-antibody response against vascular endothelium.
|
Blood
|
2009
|
1.16
|
|
89
|
Minimally oxidized LDL offsets the apoptotic effects of extensively oxidized LDL and free cholesterol in macrophages.
|
Arterioscler Thromb Vasc Biol
|
2006
|
1.14
|
|
90
|
Lysine-phosphatidylcholine adducts in kringle V impart unique immunological and potential pro-inflammatory properties to human apolipoprotein(a).
|
J Biol Chem
|
2003
|
1.13
|
|
91
|
Inhibition of PCSK9: a powerful weapon for achieving ideal LDL cholesterol levels.
|
Proc Natl Acad Sci U S A
|
2009
|
1.12
|
|
92
|
Deficiency of antigen-presenting cell invariant chain reduces atherosclerosis in mice.
|
Circulation
|
2010
|
1.11
|
|
93
|
Relationship of oxidized phospholipids and biomarkers of oxidized low-density lipoprotein with cardiovascular risk factors, inflammatory biomarkers, and effect of statin therapy in patients with acute coronary syndromes: Results from the MIRACL (Myocardial Ischemia Reduction With Aggressive Cholesterol Lowering) trial.
|
J Am Coll Cardiol
|
2009
|
1.11
|
|
94
|
Increased plasma oxidized phospholipid:apolipoprotein B-100 ratio with concomitant depletion of oxidized phospholipids from atherosclerotic lesions after dietary lipid-lowering: a potential biomarker of early atherosclerosis regression.
|
Arterioscler Thromb Vasc Biol
|
2006
|
1.10
|
|
95
|
Relationship of IgG and IgM autoantibodies and immune complexes to oxidized LDL with markers of oxidation and inflammation and cardiovascular events: results from the EPIC-Norfolk Study.
|
J Lipid Res
|
2011
|
1.09
|
|
96
|
A natural antibody to oxidized cardiolipin binds to oxidized low-density lipoprotein, apoptotic cells, and atherosclerotic lesions.
|
Arterioscler Thromb Vasc Biol
|
2006
|
1.08
|
|
97
|
Plasma triacylglycerol and HDL cholesterol concentrations confirm self-reported changes in carbohydrate and fat intakes in women in a diet intervention trial.
|
J Nutr
|
2004
|
1.08
|
|
98
|
B-cell aortic homing and atheroprotection depend on Id3.
|
Circ Res
|
2011
|
1.07
|
|
99
|
Lipoprotein-associated phospholipase A2 activity, ferritin levels, metabolic syndrome, and 10-year cardiovascular and non-cardiovascular mortality: results from the Bruneck study.
|
Eur Heart J
|
2008
|
1.06
|
|
100
|
Phospholipid transfer protein deficiency protects circulating lipoproteins from oxidation due to the enhanced accumulation of vitamin E.
|
J Biol Chem
|
2002
|
1.06
|
|
101
|
Oxidation-specific epitopes and immunological responses: Translational biotheranostic implications for atherosclerosis.
|
Curr Opin Pharmacol
|
2013
|
1.06
|
|
102
|
Inhibition of 12/15-lipoxygenase as therapeutic strategy to treat stroke.
|
Ann Neurol
|
2012
|
1.05
|
|
103
|
High-level lipoprotein [a] expression in transgenic mice: evidence for oxidized phospholipids in lipoprotein [a] but not in low density lipoproteins.
|
J Lipid Res
|
2005
|
1.04
|
|
104
|
Determinants of binding of oxidized phospholipids on apolipoprotein (a) and lipoprotein (a).
|
J Lipid Res
|
2013
|
1.04
|
|
105
|
Antisense oligonucleotides for the treatment of dyslipidaemia.
|
Eur Heart J
|
2012
|
1.03
|
|
106
|
Natural antibodies in murine atherosclerosis.
|
Curr Drug Targets
|
2008
|
1.02
|
|
107
|
Long-term effect of combined vitamins E and C on coronary and peripheral endothelial function.
|
J Am Coll Cardiol
|
2004
|
1.01
|
|
108
|
Relationship between biomarkers of oxidized low-density lipoprotein, statin therapy, quantitative coronary angiography, and atheroma: volume observations from the REVERSAL (Reversal of Atherosclerosis with Aggressive Lipid Lowering) study.
|
J Am Coll Cardiol
|
2008
|
1.01
|
|
109
|
4F Peptide reduces nascent atherosclerosis and induces natural antibody production in apolipoprotein E-null mice.
|
FASEB J
|
2010
|
0.99
|
|
110
|
Innate response activator B cells aggravate atherosclerosis by stimulating T helper-1 adaptive immunity.
|
Circulation
|
2014
|
0.99
|
|
111
|
Increased expression of oxidation-specific epitopes and apoptosis are associated with haptoglobin genotype: possible implications for plaque progression in human atherosclerosis.
|
J Am Coll Cardiol
|
2012
|
0.99
|
|
112
|
In vivo detection of oxidation-specific epitopes in atherosclerotic lesions using biocompatible manganese molecular magnetic imaging probes.
|
J Am Coll Cardiol
|
2012
|
0.98
|
|
113
|
Assessment of atherosclerotic risk factors and endothelial function in children and young adults with pediatric-onset systemic lupus erythematosus.
|
Arthritis Rheum
|
2004
|
0.98
|
|
114
|
Oxidation-specific biomarkers and risk of peripheral artery disease.
|
J Am Coll Cardiol
|
2013
|
0.96
|
|
115
|
Changes in lipoprotein(a), oxidized phospholipids, and LDL subclasses with a low-fat high-carbohydrate diet.
|
J Lipid Res
|
2010
|
0.95
|
|
116
|
Inhibition of arterial lesion progression in CD16-deficient mice: evidence for altered immunity and the role of IL-10.
|
Cardiovasc Res
|
2010
|
0.95
|
|
117
|
MCP-1 binds to oxidized LDL and is carried by lipoprotein(a) in human plasma.
|
J Lipid Res
|
2013
|
0.95
|
|
118
|
Oxidized phospholipids impair pulmonary antibacterial defenses: evidence in mice exposed to cigarette smoke.
|
Biochem Biophys Res Commun
|
2012
|
0.94
|
|
119
|
Deletion of the basement membrane heparan sulfate proteoglycan type XVIII collagen causes hypertriglyceridemia in mice and humans.
|
PLoS One
|
2010
|
0.94
|
|
120
|
Peptide mimotopes of malondialdehyde epitopes for clinical applications in cardiovascular disease.
|
J Lipid Res
|
2012
|
0.93
|
|
121
|
Oxidized low-density lipoprotein in children with familial hypercholesterolemia and unaffected siblings: effect of pravastatin.
|
J Am Coll Cardiol
|
2006
|
0.92
|
|
122
|
The inhibitory FcγRIIb modulates the inflammatory response and influences atherosclerosis in male apoE(-/-) mice.
|
Atherosclerosis
|
2010
|
0.92
|
|
123
|
Rosuvastatin: an independent analysis of risks and benefits.
|
MedGenMed
|
2006
|
0.91
|
|
124
|
Mycophenolate mofetil decreases atherosclerotic lesion size by depression of aortic T-lymphocyte and interleukin-17-mediated macrophage accumulation.
|
J Am Coll Cardiol
|
2011
|
0.91
|
|
125
|
Oxidized low-density lipoprotein autoantibodies, chronic infections, and carotid atherosclerosis in a population-based study.
|
J Am Coll Cardiol
|
2006
|
0.90
|
|
126
|
Local expression of platelet-activating factor-acetylhydrolase reduces accumulation of oxidized lipoproteins and inhibits inflammation, shear stress-induced thrombosis, and neointima formation in balloon-injured carotid arteries in nonhyperlipidemic rabbits.
|
Circulation
|
2005
|
0.89
|
|
127
|
ApoC-III inhibits clearance of triglyceride-rich lipoproteins through LDL family receptors.
|
J Clin Invest
|
2016
|
0.89
|
|
128
|
Alterations in plasma vitamin E distribution in type 2 diabetic patients with elevated plasma phospholipid transfer protein activity.
|
Diabetes
|
2004
|
0.87
|
|
129
|
Inhibition of the renin-angiotensin system abolishes the proatherogenic effect of uremia in apolipoprotein E-deficient mice.
|
Arterioscler Thromb Vasc Biol
|
2007
|
0.85
|
|
130
|
Promise of immune modulation to inhibit atherogenesis.
|
J Am Coll Cardiol
|
2007
|
0.85
|
|
131
|
Effects of pitavastatin and atorvastatin on lipoprotein oxidation biomarkers in patients with dyslipidemia.
|
Atherosclerosis
|
2012
|
0.84
|
|
132
|
Autoantibodies to OxLDL fail to alter the clearance of injected OxLDL in apolipoprotein E-deficient mice.
|
J Lipid Res
|
2004
|
0.83
|
|
133
|
The I4399M variant of apolipoprotein(a) is associated with increased oxidized phospholipids on apolipoprotein B-100 particles.
|
Atherosclerosis
|
2009
|
0.82
|
|
134
|
Circulating oxidized low-density lipoprotein is increased in hypertension.
|
Clin Sci (Lond)
|
2003
|
0.81
|
|
135
|
'LDL-C' = LDL-C + Lp(a)-C: implications of achieved ultra-low LDL-C levels in the proprotein convertase subtilisin/kexin type 9 era of potent LDL-C lowering.
|
Curr Opin Lipidol
|
2015
|
0.81
|
|
136
|
Acute impact of apheresis on oxidized phospholipids in patients with familial hypercholesterolemia.
|
J Lipid Res
|
2012
|
0.81
|
|
137
|
Relationship of a comprehensive panel of plasma oxidized low-density lipoprotein markers to angiographic restenosis in patients undergoing percutaneous coronary intervention for stable angina.
|
Am Heart J
|
2005
|
0.80
|
|
138
|
Development and application of a nonradioactive binding assay of oxidized low-density lipoprotein to macrophage scavenger receptors.
|
J Lipid Res
|
2013
|
0.80
|
|
139
|
Imaging of oxidation-specific epitopes with targeted nanoparticles to detect high-risk atherosclerotic lesions: progress and future directions.
|
J Cardiovasc Transl Res
|
2014
|
0.79
|
|
140
|
SYK regulates macrophage MHC-II expression via activation of autophagy in response to oxidized LDL.
|
Autophagy
|
2015
|
0.79
|
|
141
|
Design and synthesis of a stable oxidized phospholipid mimic with specific binding recognition for macrophage scavenger receptors.
|
J Med Chem
|
2012
|
0.79
|
|
142
|
Lipid oxidation in carriers of lecithin:cholesterol acyltransferase gene mutations.
|
Arterioscler Thromb Vasc Biol
|
2012
|
0.77
|
|
143
|
IGHV1-69-encoded antibodies expressed in chronic lymphocytic leukemia react with malondialdehyde-acetaldehyde adduct, an immunodominant oxidation-specific epitope.
|
PLoS One
|
2013
|
0.76
|
|
144
|
Research resource: Comparative nuclear receptor atlas: basal and activated peritoneal B-1 and B-2 cells.
|
Mol Endocrinol
|
2011
|
0.76
|
|
145
|
Mechanical aortic injury in apoE-deficient mice as a model for development of atherosclerosis: demonstration of leukocyte rolling early after injury.
|
Ultrastruct Pathol
|
2002
|
0.76
|
|
146
|
Fifty years of research on lipids.
|
J Lipid Res
|
2009
|
0.76
|
|
147
|
Intermittent hypoxia and hypercapnia induce pulmonary artery atherosclerosis and ventricular dysfunction in low density lipoprotein receptor deficient mice.
|
J Appl Physiol (1985)
|
2013
|
0.76
|
|
148
|
Is atherosclerosis an allergic disease?
|
Circ Res
|
2011
|
0.75
|
|
149
|
When monocytes come (too) close to our hearts.
|
J Am Coll Cardiol
|
2010
|
0.75
|
|
150
|
Shifting the diagnosis and treatment of atherosclerosis to children and young adults: a new paradigm for the 21st century.
|
J Am Coll Cardiol
|
2002
|
0.75
|
|
151
|
In memoriam: Roger A. Davis (1945-2008).
|
J Lipid Res
|
2008
|
0.75
|